Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Aisling Capital Partners Iii Lp


  • Large Shareholder at Loxo Oncology Inc. (LOXO), 2018-07-12
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2016-07-06
  • Large Shareholder at Agile Therapeutics Inc (AGRX), 2016-06-03
  • Other at Transenterix Inc. (TRXC), 2016-02-05
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2015-12-09
  • Large Shareholder at Versartis Inc. (VSAR), 2015-01-29
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-05-22
  • Large Shareholder at Zeltiq Aesthetics Inc (ZLTQ), 2014-01-27